We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ShangPharma Innovation Inc., a global venture capital firm specializing in biomedical research and development and technology, has entered a multiyear strategic partnership with Icahn School of Medicine at Mount Sinai (ISMMS)